SP10.1.5 Are we utilising the predictive potential of FIT during a time of resource scarcity?

Abstract Aims The COVID-19 pandemic has resulted in an unprecedented challenge. With the abolition of all non-urgent endoscopies nationwide, there been concerning implications on colorectal cancer (CRC) diagnosis. Rationing these scarce colonoscopy slots become a priority. Faecal immunohistochemistry test (FIT) results are predictive bowel pathology. Here we audit clinical outcomes patients that have undergone FIT our health board pre and era. Methods Using business intelligence methods, automated system for NHS eHealth data collection established. All who testing audited including investigation Results from December 2018-2019 (pre-COVID) were compared to 2019-January 2021 (COVID). There was 70.12% increase uptake. 58.88% female. Median age 73 (range 1-100). below. Conclusion Our approach improved uptake community. proportionally higher rates diagnosis with less resources. specificity is 98.64% therefore should be further widely accepted ration